The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

Good evening. Here is the Monday, October 21 edition of Today in Slovakia - the main news of the day in less than five ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% ...

The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...

The global ruminant vaccines market, valued at USD 3.51 billion in 2023, is projected to grow significantly at a compound annual growth rate (CAGR) of 6.95% from 2024 to 2032. Read the Market Summary ...

In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of ...

First patient dosed with ISP-001 shows reduced urinary GAG level, functional improvements surpassing enzyme replacement therapy in Phase I trial.

Patients undergoing bowel cancer treatment at Sheffield Teaching Hospitals NHS Foundation Trust will be invited to try out ...

A comprehensive review in JAMA outlines monkeypox's clinical presentation and management, stressing the need for increased ...

Foreign animal diseases are a global threat to swine production with the potential for detrimental economic implications.

Following the success of the COVID-19 vaccines, mRNA vaccines have now entered development for a wide range of infectious diseases. This Review discusses mRNA vaccine design considerations ...

In January last year, German biotech company BioNTech acquired African AI startup InstaDeep for over $550 million, a deal ...